Two Sigma Securities’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-22,814
| Closed | -$9.58K | – | 2391 |
|
|
2024
Q4 | $9.58K | Buy |
+22,814
| New | +$19.1K | ﹤0.01% | 1440 |
|
|
2023
Q4 | – | Sell |
-2,518
| Closed | -$55.6K | – | 3753 |
|
|
2023
Q3 | $55.6K | Buy |
+2,518
| New | +$65.7K | ﹤0.01% | 2461 |
|
|
2022
Q4 | – | Sell |
-12
| Closed | -$7K | – | 3405 |
|
|
2022
Q3 | $7K | Buy |
12
+8
| +200% | +$5.26K | ﹤0.01% | 2450 |
|
|
2022
Q2 | $3K | Buy |
+4
| New | +$5.93K | ﹤0.01% | 2130 |
|
|
2022
Q1 | – | Sell |
-11
| Closed | -$29K | – | 2626 |
|
|
2021
Q4 | $29K | Buy |
11
+6
| +120% | +$20.9K | ﹤0.01% | 1365 |
|
|
2021
Q3 | $23K | Buy |
+5
| New | +$25.2K | ﹤0.01% | 1454 |
|
|
2021
Q1 | – | Sell |
-4
| Closed | -$22K | – | 1900 |
|
|
2020
Q4 | $22K | Buy |
+4
| New | +$24.5K | ﹤0.01% | 1598 |
|
|
2020
Q2 | – | Sell |
-6
| Closed | -$20K | – | 1834 |
|
|
2020
Q1 | $20K | Buy |
+6
| New | +$24.9K | ﹤0.01% | 1227 |
|
Two Sigma Securities's TTOO Position: Q1 2025 in Review
Two Sigma Securities sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 22,814 shares — an estimated $9.58K sold.
Two Sigma Securities first reported a position in TTOO in Q1 2020 and held it in 8 quarters. The position peaked at $55.6K in Q3 2023. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Two Sigma Securities reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Two Sigma Securities sold 22,814 T2 Biosystems, Inc shares in Q1 2025, an estimated $9.58K.
- Two Sigma Securities first reported a position in T2 Biosystems, Inc in Q1 2020 and held it in 8 quarters.
- Two Sigma Securities's T2 Biosystems, Inc position peaked at $55.6K in Q3 2023.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.